Menu
Recruiting NCT07102082

Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

No phase Interventional Smoking Behaviors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Modified Risk - None, Modified Risk Claim.
Who it may be relevant to
Registry conditions: Smoking Behaviors. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect

Overview

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Detailed description

Primary Objectives:

To assess the influence of smokeless tobacco products' modified risk claims on:

1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and 2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.

Interventions

  • Behavioral Modified Risk - None
    Participants view ads with no modified risk claim
  • Behavioral Modified Risk Claim
    Participants view ads with a modified risk claim

Primary outcome measures

  • Demand for cigarettes [Time frame: After one session - 1 hour]
  • Increase in knowlege of tobacco-associated diseases [Time frame: After one session - I hour]

Eligibility criteria

Inclusion criteria

  • Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
  • Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
  • Open to trying a non-combusted oral tobacco product.
  • Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
  • Have the ability to read, write, and communicate in English.
  • Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

Exclusion criteria

  • Plan to quit smoking in the next 30 days.
  • Use of smokeless tobacco at least weekly in the last 6 months.
  • Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
  • Unwilling or unable to follow protocol requirements.
  • Pregnant or planning to become pregnant (by self report)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • Roswell Park — Buffalo

Identifiers

NCT: NCT07102082 · I-4008824 · R21CA289541

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗